Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T23:08:52.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    2%
    Check dated 2024-12-07T17:25:31.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, melanoma, and clinical trials have been removed, which may impact access to important medical information and resources.
    Difference
    4%
    Check dated 2024-11-23T05:07:55.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The website has been updated to version 2.12.2, with new additions including links to genetics resources, clinical trial documents, and drug information for melanoma treatments such as Trametinib, Dabrafenib, and Pembrolizumab.
    Difference
    4%
    Check dated 2024-11-08T18:34:57.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.0 to 2.12.1.
    Difference
    0.1%
    Check dated 2024-11-01T10:55:22.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential improvements or features.
    Difference
    0.1%
    Check dated 2024-10-25T00:49:39.000Z thumbnail image

Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.